Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director comp.
Acq. announced
Appointed director

Akili, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Akili Announces Leadership Transition"
08/10/2023 8-K Quarterly results
Docs: "Akili Reports Second Quarter 2023 Financial Results and Provides Business Update"
06/07/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Akili Releases EndeavorOTC TM Video Game Treatment to Improve Attention in Adults with ADHD"
05/12/2023 8-K/A Quarterly results
Docs: "Akili Reports First Quarter 2023 Financial Results and Provides Business Update"
05/11/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Akili Reports First Quarter 2023 Financial Results and Provides Business Update"
05/04/2023 8-K Quarterly results
03/07/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update"
01/12/2023 8-K Cost Associated with Exit or Disposal Activities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ...
Docs: "Akili, Inc. Chief Executive Officer Email to Employees, January 12, 2023"
01/05/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Pivotal Trial of EndeavorRx ® in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes"
10/27/2022 8-K Quarterly results
10/17/2022 8-K Regulation FD Disclosure  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
08/23/2022 8-K Director compensation was amended/approved, Acquisition/merger/asset purchase announced
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Certificate of Incorporation of Akili, Inc",
"Bylaws of Akili, Inc",
"Form of Indemnification Agreement for Executive Officers",
"Form of Indemnification Agreement for Directors",
"2022 Stock Option and Incentive Plan of Akili, Inc. and forms of agreement thereunder",
"Cover Page Interactive Data File (formatted as Inline XBRL)",
"AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT",
"LOCK-UP AGREEMENT",
"Code of Ethics of Akili, Inc",
"Letter from Marcum LLP to the Securities and Exchange Commission"
08/19/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Digital Medicine Leader Akili to List on Nasdaq Following Successful Business Combination with Social Capital Suvretta Holdings Corp. I"
07/08/2022 8-K Appointed a new director
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Letter Agreement, between the Company and Mr. Taylor",
"Indemnity Agreement, between the Company and Mr. Taylor"
05/20/2022 8-K/A Quarterly results
04/22/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "FORM 8-K",
"Promissory Note"
01/27/2022 8-K/A Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "FORM 8-K/A",
"Agreement and Plan of Merger",
"Form of Subscription Agreement",
"Sponsor Support Agreement",
"Akili Holders Support Agreement",
"Certain Historical Financial Information of Akili"
01/26/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I",
"Investor Presentation"
11/16/2021 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review &nbsp...
09/24/2021 8-K Quarterly results
07/09/2021 8-K Quarterly results
07/02/2021 8-K Appointed a new director
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : June 29, 2021 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I Commission file number: 001-40558 Cayman Islands 98-1586159 2850 W. Horizon Ridge Parkway, Suite 200 Henderson, NV 89052 -521-9008 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commenc...",
"Underwriting Agreement, between the Company and Morgan Stanley & Co. LLC",
"Amended and Restated Memorandum and Articles of Association of the Company",
"Letter Agreement, among the Company, the Sponsor and the Company's officers and directors",
"Investment Management Trust Agreement, between the Company and Continental Stock Transfer & Trust Company, as trustee",
"Registration Rights Agreement, among the Company and certain other security holders named therein",
"Administrative Services Agreement, between the Company and Social + Capital Partnership, LLC",
"Private Placement Shares Purchase Agreement, between the Company and the Sponsor",
"Form of Indemnity Agreement, between the Company and each of its officers and directors",
"Social Capital Suvretta Holdings Corp. I Announces Pricing of Upsized $220,000,000 Initial Public Offering PALO ALTO, Calif., Jun. 30, 2021 /Business Wire/ — Social Capital Suvretta Holdings Corp. I announced today that it has priced its upsized initial public offering of 22,000,000 Class A ordinary shares at $10.00 per share. The Class A ordinary shares will be listed on the Nasdaq Capital Market and trade under the ticker symbol “DNAA” beginning June 30, 2021. The Company is led by Chamath Palihapitiya and Kishen Mehta and is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on businesses operating in t..."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy